Issue 17/2007
Content (16 Articles)
Comment on “Adjuvant Therapy in Pancreatic Cancer: A Critical Appraisal”
- Commentary
Paula Ghaneh, Catrin Tudur-Smith, John P. Neoptolemos
Adjuvant Therapy in Pancreatic Cancer: A Critical Appraisal — The Authors’ Reply
- Commentary
Helmut Oettle, Peter Neuhaus
Potential Pharmacological Interventions in Polycystic Kidney Disease
- Leading Article
Amirali Masoumi, Berenice Reed-Gitomer, Catherine Kelleher, Robert W. Schrier
Crohn’s Disease
- Review Article
Julián Panés, Fernando Gomollón, Carlos Taxonera, Joaquin Hinojosa, Juan Clofent, Vilar Nos
Pharmacotherapy for Oesophagogastric Cancer
- Review Article
Christopher Jackson, Naureen Starling, Yu Jo Chua, David Cunningham
Delayed-Release Multi Matrix System (MMX™) Mesalazine
- Adis Drug Profile
Paul L. McCormack, Dean M. Robinson, Caroline M. Perry
Delayed-Release Multi Matrix System (MMX™) Mesalazine in Ulcerative Colitis
- Adis Drug Profiles
Åke Nilsson
Delayed-Release Multi Matrix System (MMX™) Mesalazine in Ulcerative Colitis
- Adis Drug Profiles
Cosimo Prantera
Imatinib in Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia
- Adis Drug Profiles
Joseph Brandwein
Imatinib in Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia
- Adis Drug Profiles
Ronan Swords
Imatinib in Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia
- Adis Drug Profiles
Barbara Wassmann